OrbiMed’s BrightSpring Health Services BTSG Stock Holding History

OrbiMed’s Portfolio BTSG Stock Details BTSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-150,000	Closed	-$4.43M	–	131
2025 Q3	$4.43M	Buy	+150,000	New	+$3.49M	0.1%	89

Other funds holding BTSG

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OrbiMed's BTSG Position: Q2 2026 in Review

OrbiMed sold out of BrightSpring Health Services (BTSG) in Q2 2026, closing a stake of 497,800 shares — an estimated $21.2M sold.

OrbiMed first reported a position in BTSG in Q3 2025 and held it in 3 quarters. The position peaked at $21.2M in Q1 2026. 423 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

OrbiMed reported no remaining BrightSpring Health Services position as of Q2 2026 after selling out during the quarter.
OrbiMed sold 497,800 BrightSpring Health Services shares in Q2 2026, an estimated $21.2M.
OrbiMed first reported a position in BrightSpring Health Services in Q3 2025 and held it in 3 quarters.
OrbiMed's BrightSpring Health Services position peaked at $21.2M in Q1 2026.
423 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.